At close: January 3 at 4:00:02 PM EST
After hours: January 3 at 4:20:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-119,488.00
-154,183.00
-206,459.00
-182,270.00
-83,428.00
Investing Cash Flow
-28,429.00
249,226.00
-336,513.00
-38,798.00
104,834.00
Financing Cash Flow
-27.00
31.00
1,895.00
8,182.00
717,377.00
End Cash Position
204,048.00
291,831.00
196,757.00
737,834.00
950,720.00
Interest Paid Supplemental Data
--
13.00
18.00
22.00
25.00
Capital Expenditure
-27,760.00
-41,427.00
-47,363.00
-63,298.00
-6,998.00
Issuance of Capital Stock
--
--
--
--
612,016.00
Repayment of Debt
--
--
--
--
-5.00
Repurchase of Capital Stock
--
--
--
--
-487.00
Free Cash Flow
-147,248.00
-195,610.00
-253,822.00
-245,568.00
-90,426.00
12/31/2020 - 10/4/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MNPR Monopar Therapeutics Inc.
22.98
+3.42%
ARQT Arcutis Biotherapeutics, Inc.
14.62
+0.41%
MSB.AX Mesoblast Limited
3.1700
-5.37%
ALLK Allakos Inc.
1.1600
-6.45%
ALXO ALX Oncology Holdings Inc.
1.8100
+16.03%
OMER Omeros Corporation
11.21
+13.92%
BCRX BioCryst Pharmaceuticals, Inc.
7.70
-1.66%
IGMS IGM Biosciences, Inc.
6.56
+5.64%
BCYC Bicycle Therapeutics plc
14.89
+3.69%
OCUL Ocular Therapeutix, Inc.
8.76
+0.23%